Comparison of patients with (41) and without (35) osteoporosis at presentation and follow-up.

The mean follow-up period was 14 months. In both the non-osteoporosis and the osteoporosis group, the LS-BMD significantly increased. At the end of the period, the cumulative dose of prednisolone and the LS-BMD differential were greater in the osteoporosis group.NS*: p>0.05 between the osteoporosis and non-osteoporosis group.Abbreviations: LS-BMD, lumbar spine bone mineral density; H-BMD, hip bone mineral density; FN-BMD, femoral neck bone mineral density; T score, number of standard deviations (SD) different from the mean value of the corresponding gender-matched young adult mean BMD. DM, diabetes mellitus; BUN, blood urea nitrogen; Cr, blood creatinine; Ca, serum calcium concentration; P, serum inorganic phosphate level; TC, serum total cholesterol level; TG, serum triglyceride level; NS: not significant, p>0.05.